SCHEMBL1993722

SCHEMBL1993722

CCN(CC)CCCS(=O)(=O)N[C@H](CCc1ccccc1)c1nc(-c2ccc(Cl)cc2)n[nH]1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.81
SLC2A1 P11166 1/20 0.40
NR1H2 P55055 2/20 0.39
S1PR1 P21453 1/20 0.39
S1PR3 Q99500 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HDAC9 Q9UKV0 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38
TP53 P04637 1/20 0.35
SLC6A3 Q01959 3/20 0.35
NR1H3 Q13133 1/20 0.35
CCR4 P51679 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1981207 0.91 GHSR (0.81) GHSRSLC2A1HDAC3HDAC4HDAC1
SCHEMBL1981210 0.91 GHSR (0.81) GHSRSLC2A1HDAC3HDAC4HDAC1
SCHEMBL1994335 0.91 GHSR (0.81) GHSRHDAC3HDAC4HDAC1HDAC7
SCHEMBL1992391 0.91 GHSR (0.72) GHSRS1PR1S1PR3HDAC3HDAC4
SCHEMBL1989497 0.90 GHSR (0.80) GHSRHDAC3HDAC4HDAC1HDAC7
SCHEMBL1990385 0.90 GHSR (1.00) GHSRHDAC3HDAC4HDAC1HDAC7
SCHEMBL1989820 0.89 GHSR (0.78) GHSRHDAC3HDAC4HDAC1HDAC7
SCHEMBL1988495 0.87 GHSR (0.62) GHSRS1PR1TP53SLC6A3CCR4
SCHEMBL17631733 0.87 GHSR (0.82) GHSRHDAC3HDAC4HDAC1HDAC7
SCHEMBL1984635 0.86 GHSR (0.69) GHSRS1PR1S1PR3HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152232-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF SAUNDERS JEFFREY O 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152232-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF GHSR, GHRHR, SSTR2 GHSR 1/4885SLC2A1 337/4885NR1H2 452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.